메뉴 건너뛰기




Volumn 167, Issue 2, 2013, Pages 132-136

Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: A systematic review and meta-analysis

Author keywords

Fluconazol; Meta analysis; Systematic review; Vulvovaginal candidiasis

Indexed keywords

FLUCONAZOLE;

EID: 84884213686     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2012.12.001     Document Type: Article
Times cited : (44)

References (26)
  • 2
    • 33746774864 scopus 로고    scopus 로고
    • Sexually transmitted diseases treatment guidelines, 2006
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention, K.A. Workowski, and S.M. Berman Sexually transmitted diseases treatment guidelines, 2006 MMWR Recommendations and Reports 55 2006 51 56
    • (2006) MMWR Recommendations and Reports , vol.55 , pp. 51-56
    • Workowski, K.A.1    Berman, S.M.2
  • 3
    • 17644367218 scopus 로고    scopus 로고
    • Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis
    • O. Babula, G. Lazdane, J. Kroica, I.M. Linhares, W.J. Ledger, and S.S. Witkin Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis Clinical Infectious Diseases 40 2005 1258 1262
    • (2005) Clinical Infectious Diseases , vol.40 , pp. 1258-1262
    • Babula, O.1    Lazdane, G.2    Kroica, J.3    Linhares, I.M.4    Ledger, W.J.5    Witkin, S.S.6
  • 4
    • 0031938872 scopus 로고    scopus 로고
    • Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group
    • M.F. Cotch, S.L. Hillier, R.S. Gibbs, and D.A. Eschenbach Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group American Journal of Obstetrics and Gynecology 178 1998 374 380
    • (1998) American Journal of Obstetrics and Gynecology , vol.178 , pp. 374-380
    • Cotch, M.F.1    Hillier, S.L.2    Gibbs, R.S.3    Eschenbach, D.A.4
  • 6
    • 0038310868 scopus 로고    scopus 로고
    • Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: Postmarketing surveillance data in England
    • L. Wilton, M. Kollarova, E. Heeley, and S. Shakir Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England Drug Safety 26 2003 589 597
    • (2003) Drug Safety , vol.26 , pp. 589-597
    • Wilton, L.1    Kollarova, M.2    Heeley, E.3    Shakir, S.4
  • 7
    • 18744378563 scopus 로고    scopus 로고
    • Prevalence and risk factors for vaginal candida colonization in women with type 1 and type 2 diabetes
    • E.M. de Leon, S.J. Jacober, J.D. Sobel, and B. Foxman Prevalence and risk factors for vaginal candida colonization in women with type 1 and type 2 diabetes BMC Infectious Diseases 2 2002 1 4
    • (2002) BMC Infectious Diseases , vol.2 , pp. 1-4
    • De Leon, E.M.1    Jacober, S.J.2    Sobel, J.D.3    Foxman, B.4
  • 8
    • 0347917130 scopus 로고    scopus 로고
    • Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis
    • B.D. Reed, P. Zazove, and C.L. Pierson Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis Journal of Women's Health 12 2003 979 989
    • (2003) Journal of Women's Health , vol.12 , pp. 979-989
    • Reed, B.D.1    Zazove, P.2    Pierson, C.L.3
  • 9
    • 0037337958 scopus 로고    scopus 로고
    • Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severity
    • A. Duerr, C.M. Heilig, and S.F. Meikle Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: risk factors and severity Obstetrics and Gynecology 101 2003 548 556
    • (2003) Obstetrics and Gynecology , vol.101 , pp. 548-556
    • Duerr, A.1    Heilig, C.M.2    Meikle, S.F.3
  • 11
    • 0022884243 scopus 로고
    • Recurrent vulvovaginal candidiasis: A prospective study of the efficacy of maintenance ketoconazole therapy
    • J.D. Sobel Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy New England Journal of Medicine 315 1986 1455 1458
    • (1986) New England Journal of Medicine , vol.315 , pp. 1455-1458
    • Sobel, J.D.1
  • 12
    • 0018100917 scopus 로고
    • Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment
    • F. Davidon, and R.F. Mould Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment British Journal of Venereal Diseases 54 1978 176 183
    • (1978) British Journal of Venereal Diseases , vol.54 , pp. 176-183
    • Davidon, F.1    Mould, R.F.2
  • 13
    • 4143079095 scopus 로고    scopus 로고
    • Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis
    • J.D. Sobel, H.C. Wiesenfeld, and M. Martens Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis New England Journal of Medicine 351 2004 876 883
    • (2004) New England Journal of Medicine , vol.351 , pp. 876-883
    • Sobel, J.D.1    Wiesenfeld, H.C.2    Martens, M.3
  • 14
    • 0025347037 scopus 로고
    • Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis
    • E.T. Houang, O. Chappatte, and D. Byrne Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis Antimicrobial Agents and Chemotherapy 34 1990 909 910
    • (1990) Antimicrobial Agents and Chemotherapy , vol.34 , pp. 909-910
    • Houang, E.T.1    Chappatte, O.2    Byrne, D.3
  • 15
    • 77956321783 scopus 로고    scopus 로고
    • Assessing risks of bias in included studies
    • Higgins J, Green S, editors Oxford, England: Cochrane Collaboration, 2008:chap 8
    • Higgins J, Altmann DG. Assessing risks of bias in included studies. In: Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions 5.0.1. Oxford, England: Cochrane Collaboration, 2008:chap 8.
    • Cochrane Handbook for Systematic Reviews of Interventions 5.0.1
    • Higgins, J.1    Altmann, D.G.2
  • 17
    • 84884211706 scopus 로고    scopus 로고
    • Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008
    • Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
  • 18
    • 76249134474 scopus 로고    scopus 로고
    • Effectiveness of Fluconazole for suppressive maintenance therapy in patients with RVVC: A Randomized Placebo-Controlled Study
    • F. Bolouri, N.M. Tabriz, and F.D. Tanha Effectiveness of Fluconazole for suppressive maintenance therapy in patients with RVVC: a Randomized Placebo-Controlled Study Iranian Journal of Pharmaceutical Research 8 2009 307 313
    • (2009) Iranian Journal of Pharmaceutical Research , vol.8 , pp. 307-313
    • Bolouri, F.1    Tabriz, N.M.2    Tanha, F.D.3
  • 19
    • 0033400145 scopus 로고    scopus 로고
    • Current evaluation and management of vulvovaginitis
    • H.K. Haefner Current evaluation and management of vulvovaginitis Clinical Obstetrics and Gynecology 42 1999 184 195
    • (1999) Clinical Obstetrics and Gynecology , vol.42 , pp. 184-195
    • Haefner, H.K.1
  • 21
    • 2042504392 scopus 로고    scopus 로고
    • History and new insights into host defense against vaginal candidiasis
    • P.L. Fidel Jr. History and new insights into host defense against vaginal candidiasis Trends in Microbiology 12 2004 220 227
    • (2004) Trends in Microbiology , vol.12 , pp. 220-227
    • Fidel, Jr.P.L.1
  • 22
    • 32644433583 scopus 로고    scopus 로고
    • Fluconazole for the management of invasive candidiasis: Where do we stand after 15 years?
    • C. Charlier, E. Hart, and A. Lefort Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? Journal of Antimicrobial Chemotherapy 57 2006 384 410
    • (2006) Journal of Antimicrobial Chemotherapy , vol.57 , pp. 384-410
    • Charlier, C.1    Hart, E.2    Lefort, A.3
  • 24
    • 33750852015 scopus 로고    scopus 로고
    • Management of recurrent vulvovaginal candidiasis: Unresolved issues
    • J.D. Sobel Management of recurrent vulvovaginal candidiasis: unresolved issues Current Infectious Disease Reports 8 2006 481 486
    • (2006) Current Infectious Disease Reports , vol.8 , pp. 481-486
    • Sobel, J.D.1
  • 25
    • 0347361710 scopus 로고    scopus 로고
    • Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium
    • M.Y. Moosa, J.D. Sobel, and H. Elhalis Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium Antimicrobial Agents and Chemotherapy 48 2000 161 167
    • (2000) Antimicrobial Agents and Chemotherapy , vol.48 , pp. 161-167
    • Moosa, M.Y.1    Sobel, J.D.2    Elhalis, H.3
  • 26
    • 60549098868 scopus 로고    scopus 로고
    • Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
    • P.G. Pappas, C.A. Kauffman, and D. Andes Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America Clinical Infectious Diseases 48 2009 503 535
    • (2009) Clinical Infectious Diseases , vol.48 , pp. 503-535
    • Pappas, P.G.1    Kauffman, C.A.2    Andes, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.